232 related articles for article (PubMed ID: 10495620)
1. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
Langhammer HR; Laubenbacher C; Hirsch C; Klingele C; Spyra JL; Senekowitsch-Schmidtke R; Schwaiger M
Med Klin (Munich); 1999 Aug; 94(8):415-24. PubMed ID: 10495620
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate.
Meller J; Wisheu S; Munzel U; Behe M; Gratz S; Becker W
Eur J Nucl Med; 2000 Sep; 27(9):1286-91. PubMed ID: 11007508
[TBL] [Abstract][Full Text] [Related]
3. [First results of radioiodine therapy of multifocal and disseminated thyroid gland autonomy and use of a TcTUs-adapted dose concept].
Oexle C; Reinhardt M; Moser E
Nuklearmedizin; 1998; 37(6):192-6. PubMed ID: 9770712
[TBL] [Abstract][Full Text] [Related]
4. [Results of TcTUs-optimized radioiodine therapy in multifocal and disseminated autonomy].
Dunkelmann S; Endlicher D; Prillwitz A; Rudolph F; Groth P; Schümichen C
Nuklearmedizin; 1999; 38(5):131-9. PubMed ID: 10488479
[TBL] [Abstract][Full Text] [Related]
5. [Incidence of immunogenic hyperthyroidism after radioiodine therapy of focal thyroid gland autonomy. Results of a multicenter study].
Weiss M; Görges R; Hirsch C; Bader J; Tatsch K; Hahn K
Med Klin (Munich); 1999 May; 94(5):239-44. PubMed ID: 10408185
[TBL] [Abstract][Full Text] [Related]
6. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
[TBL] [Abstract][Full Text] [Related]
7. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy.
Reinhardt M; Emrich D; Krause T; Bräutigam P; Nitzsche E; Blattmann H; Schümichen C; Moser E
Eur J Endocrinol; 1995 May; 132(5):550-6. PubMed ID: 7749494
[TBL] [Abstract][Full Text] [Related]
8. Functional autonomies of thyroid and efficacy of radioiodine therapy.
Kraft O; Stepien A
Cancer Biother Radiopharm; 2007 Apr; 22(2):261-7. PubMed ID: 17600474
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy.
Meller J; Becker W
Q J Nucl Med; 1999 Sep; 43(3):179-87. PubMed ID: 10568133
[TBL] [Abstract][Full Text] [Related]
10. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume].
Seeger T; Emrich D; Sandrock D
Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642
[TBL] [Abstract][Full Text] [Related]
11. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
[No Abstract] [Full Text] [Related]
12. Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?
Reinhardt MJ; Biermann K; Wissmeyer M; Juengling FD; Brockmann H; von Mallek D; Ezziddin S; Joe AY; Krause TM
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):608-12. PubMed ID: 16541268
[TBL] [Abstract][Full Text] [Related]
13. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
[TBL] [Abstract][Full Text] [Related]
14. [Reduction of thyroid volume following radioiodine therapy for functional autonomy].
Luster M; Jacob M; Thelen MH; Michalowski U; Deutsch U; Reiners C
Nuklearmedizin; 1995 Apr; 34(2):57-60. PubMed ID: 7761274
[TBL] [Abstract][Full Text] [Related]
15. Scintigraphic evaluation of functional thyroidal autonomy.
Meller J; Becker W
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S45-51. PubMed ID: 9867196
[TBL] [Abstract][Full Text] [Related]
16. Decrease of (99m)Tc-uptake in autonomous thyroid tissue in Germany since the 1970s. Clinical implications for radioiodine therapy.
Gotthardt M; Stübinger M; Pansegrau J; Buchwald B; Goecke J; Pfestroff A; Corstens FH; Behr TM
Nuklearmedizin; 2006; 45(3):122-5. PubMed ID: 16710508
[TBL] [Abstract][Full Text] [Related]
17.
Zhao L; Zhang W; Xin Y; Wen Q; Bail L; Guan F; Bin J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):349-353. PubMed ID: 30413358
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
19. What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Gotthardt M; Rubner C; Bauhofer A; Berce F; Oyen WJ; Goecke J; Pfestroff A; Schlieck A; Corstens FH; Béhé M; Behr TM
Nuklearmedizin; 2006; 45(5):206-12. PubMed ID: 17043731
[TBL] [Abstract][Full Text] [Related]
20. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]